Search
for
Sort by
Research 541–570 of 1000+
- Mitochondria Dysfunction and Inflammation in Traumatic Brain Injury: Androgens to the Battlefront
- Differential Expression of CXCL12 in Human and Mouse Hair: Androgens Induce CXCL12 in Human Dermal Papilla and Dermal Sheath Cup
- Rare virilizing tumor: ovarian steroid cell tumor, not otherwise specified: a case report
- Side gland of Suncus murinus as a new model of sebaceous gland: 5?-reductase, androgen receptor, and nuclear androgen content in male and female animals
- Estrogen and androgen signaling in the pathogenesis of BPH
- Androgen insufficiency in women: diagnostic and therapeutic implications
- Minoxidil may suppress androgen receptor-related functions
- Deciphering the Role of Androgen in the Dermatologic Manifestations of Polycystic Ovary Syndrome Patients: A State-of-the-Art Review
- Androgens in cervical cancer: Their role in epidemiology and biology
- Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia
- Meloside A Protects Dermal Papilla Cells from DHT-Induced Damage via Androgen Receptor Modulation
- Alternative androgen pathways
- Androgen Treatment in Adolescent Males With Hypogonadism
- Androgen receptor–mediated inhibition of cutaneous wound healing
- Hirsutism, Normal Androgens and Diagnosis of PCOS
- Steroid Sulfatase Deficiency and Androgen Activation Before and After Puberty
- Restoration of Spermatogenesis and Male Fertility Using an Androgen Receptor Transgene
- Cyclin-dependent kinase inhibitors, p21waf1/cip1 and p27kip1, are expressed site- and hair cycle-dependently in rat hair follicles
- COVID-19 Severity and Androgen Receptor Polymorphism
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- Lrig1 Expression in Human Sebaceous Gland Tumors
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Structural perspectives on the androgen receptor, the elusive shape-shifter
- Long-term Prophylaxis with Androgens in the management of Hereditary Angioedema (HAE) in emerging countries
- Bioengineered polyester nanoparticles for the synergistic treatment of androgenic alopecia via the suppression of 5α-reductase and knockdown of androgen receptor
- Androgens and ovarian function: translation from basic discovery research to clinical impact
- Androgen sensitivity gateway to COVID‐19 disease severity
- Desmoplastic Trichoepithelioma: Histopathologic and Immunohistochemical Criteria for Differentiation of a Rare Benign Hair Follicle Tumor From Other Cutaneous Adnexal Tumors
- Effects of orlistat on serum androgen levels among iranian obese women with polycystic ovarian syndrome